📰 Thea Pharma News
Thea Pharma News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thea Pharma. Real-time updates on events, politics, business and more.
November 15, 2023
A Wicklow equestrian centre made a dream come true for American Paralympian Amy Dixon last week.
September 26, 2023
/PRNewswire/ -- Thea Pharma Inc. ("Thea"), the U.S. subsidiary of Europes leading independent ophthalmic-focused pharmaceutical company, Théa, dedicated to...
September 26, 2023
Iyuzeh (latanoprost ophthalmic soln) is now available for the reduction of elevated IOP in patients with open-angle glaucoma or ocular hypertension.
August 3, 2023
As the current business cycle swings into volatile territory across the country, sponsors, lenders, and management teams will be faced with difficult choices...
June 26, 2023
Théa’s Susan Benton on building a team with an eye on succession
May 7, 2023
SAN DIEGO — It may be time for a new approach to initial and stepwise interventional therapy in glaucoma, according to a speaker here.
May 1, 2023
The Global Ophthalmic Surgical Devices Market was valued at USD 8.91 billion in 2021 and growing at a CAGR of 5.09% during the forecast period (2023 to
April 28, 2023
/PRNewswire/ -- Thea Pharma Inc. ("Thea"), the U.S. subsidiary of Europes leading independent pharmaceutical company, Laboratoires Théa, dedicated to the...
December 15, 2022
The FDA has approved Iyuzeh (latanoprost ophthalmic solution) 0.005% to reduce elevated IOP in patients with open-angle glaucoma or ocular hypertension.
October 28, 2022
Tech - Making telework policies more and more flexible has increased vulnerabilities in organizations' infrastructures. The current geopolitical context is